Clinical Trials Logo
  1. Home
  2. Mild Asthma
  3. NCT02892344

Study of QMF149 (150/80 µg) Compared With MF Twisthaler® (200 µg) in Patients With Asthma

Mild Asthma Clinical Trial

Official title:
A Multi-center, Randomized, 12-week Treatment, Doubleblind Study to Assess the Efficacy and Safety of QMF149 (150/80 Microgram) Compared With MF Twisthaler® (200 Microgram) in Adult and Adolescent Patients With Asthma

Clinical Trial Summary

The purpose of the trial was to evaluate efficacy and safety of QMF149 150/80 microgram o.d. delivered via Concept1 compared to MF 200 microgram o.d., delivered via Twisthaler® in terms of lung function and symptom control in poorly (ie inadequately) controlled asthma patients. This study was to assess contribution of LABA as an add-on therapy to low dose ICS monotherapy.

Clinical Trial Description

The primary objective of this study was to demonstrate the superiority of QMF149 150/80 microgram o.d. (in the evening) delivered via Concept1 compared with MF 200 microgram o.d. (in the evening) delivered via Twisthaler® in terms of trough FEV1 after 12 weeks of treatment in adults and adolescents. The key secondary objective of this study was to demonstrate the superiority of QMF149 150/80 microgram to MF 200 microgram o.d. in terms of ACQ-7 after 12 weeks of treatment. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02892344
Study type Interventional
Source Novartis
Contact
Status Completed
Phase Phase 3
Start date January 16, 2017
Completion date November 30, 2018
View Details
See also
  Status Clinical Trial Phase
Completed NCT00380354 - Study To Evaluate GSK256066 In Subjects With Mild Bronchial Asthma Phase 2
Completed NCT00453778 - A Study To Investigate The Effect Of Inhaled Fluticasone Propionate On The Bronchial Responsiveness To Leukotriene D4 In Asthmatics Patients Phase 4
Recruiting NCT04796844 - MANI Real-life Perspective Observatory
Completed NCT00466596 - Effect of House Dust Mite Allergen Challenge in Persons Using 1200 mg Gamma Tocopherol Supplements Phase 1
Not yet recruiting NCT06433921 - A Study to Compare the Relative Potency of Salbutamol Administered Via Metered Dose Inhalers (MDI) Containing Propellants HFA-152a to HFA-134a in Mild Asthmatics Aged 18 to 65 Inclusive Phase 1
Not yet recruiting NCT06411886 - Measurements of Inflammation Induced by Allergen Inhalation Challenge in Mild Allergic Asthma N/A
Completed NCT00287365 - Genetic Susceptibility to Ozone in Mild Asthmatic Volunteers N/A
Completed NCT00448851 - Study of Dust Mite Inhalation in Humans Phase 1
Completed NCT03838731 - Study in Cat-Allergic Patients With Asthma to Evaluate the Efficacy of a Single Dose of REGN1908-1909 to Reduce Bronchoconstriction Upon Cat Allergen Challenge Phase 2
Completed NCT03421730 - A Study of the Pharmacokinetics, Safety and Tolerability of Single Doses of VR647 Inhalation Suspension Administered Using the VR647 Inhalation System in Children With Wheezing, Reactive Airway Disease or Mild Asthma Phase 1
Recruiting NCT04912596 - Pharmacodynamic Equivalence of the Test and Reference Metered Dose Inhalers (MDIs) Containing Albuterol Sulfate in Adult Patients With Stable Mild Asthma N/A